valproic acid has been researched along with luteolin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertolino, B; Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Impellizzeri, D; Siracusa, R | 1 |
| Guan, W; Han, W; Wang, R; Yu, F; Zhi, F | 1 |
2 other study(ies) available for valproic acid and luteolin
| Article | Year |
|---|---|
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.
Topics: Amides; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Autistic Disorder; Brain; Child; Chymases; Cytokines; Disease Models, Animal; Doublecortin Domain Proteins; Enzyme Inhibitors; Ethanolamines; Follow-Up Studies; Humans; Luteolin; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neuropeptides; Nitric Oxide Synthase Type II; Palmitic Acids; Tryptases; Valproic Acid | 2017 |
Valproic Acid Sensitizes Glioma Cells to Luteolin Through Induction of Apoptosis and Autophagy via Akt Signaling.
Topics: Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Drug Synergism; Glioma; Humans; Luteolin; Proto-Oncogene Proteins c-akt; Signal Transduction; Valproic Acid | 2021 |